Atlas Trials

Phase II Study of Vandetanib in Individuals With Kidney Cancer

Clinical trial NCT00566995 · COMPLETED

Trial details

NCT number
NCT00566995
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal CancerVon Hippel Lindau
Start date
2008-02-07
Primary completion
2014-06-20
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.